A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome
A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome
批准号:
405079
负责人:
Skeith Leslie
金额:
$7.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-05-01 至 2022-05-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antiphospholipid syndrome (APS) is an autoimmune disease that can lead to blood clots (thrombosis) or complications in pregnancy such as pregnancy loss, pre-eclampsia or intrauterine growth restriction because of placental insufficiency. The cause of APS
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
-
批准号:498295
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Skeith Leslie
-
依托单位:
A prospective cohort study evaluating peripartum anticoagulation management among pregnant women with VTE and its impact on patient outcomes
-
批准号:434526
-
项目类别:Operating Grants
-
资助金额:$54.06万
-
财政年份:2020
-
负责人:Skeith Leslie
-
依托单位:
A pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin in postpartum women at risk of developing venous thromboembolism (pilot PAPS: Postpartum Aspirin Prophylaxis Study)
-
批准号:401960
-
项目类别:Operating Grants
-
资助金额:$33.16万
-
财政年份:2019
-
负责人:Skeith Leslie
-
依托单位:
海外基金